European Registry of Transcatheter Repair for Tricuspid Regurgitation (EuroTR)

LMU Klinikum

Status: Enrolling

Conditions: Valvular Heart Disease; Heart Failure; Tricuspid Regurgitation

Treatments: Device: T-TEER

Study type: Observational

Funder types: Other

Identifiers

NCT06307262

EuroTR Registry

Details and patient eligibility

About

To investigate clinical and survival outcomes following transcatheter tricuspid valve repair or replacement.

Full description

Background and Rationale:

Tricuspid regurgitation (TR) is a major health and economic burden due to high rates of heart failure hospitalizations, morbidity and mortality. Surcial treatment of TR is associated with high procedural and in-hospital mortality. Due to prohibitive surgical risk, a significant proportion of patients historically remained untreted beyond medical therapy. Transcatheter tricuspid valve (TV) repair and replacement techniques (TTVT) now offer a new treatment perspective for these patients. The EuroTR registry aims at optimizing patient selection prior to TTVT and thus treatment quality by collecting respective data in a real-world setting.

Objectives:

To investigate clinical and survival outcome following transcatheter tricuspid valve repair or replacement.

Enrollment: 3,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Patients treated with one of the following transcatheter devices for TV repair or replacement: PASCAL, TriClip, TricValve, Evoque, LuX-Valve
• Age ≥ 18 years